Maria Teresa Landi

Landi completed an M.D. summa cum laude from the University of Milan and was trained in oncology and general medicine at the San Raffaele Hospital.^[1] She earned a Ph.D. in occupational medicine and industrial hygiene, a subgroup of molecular epidemiology, from an Italian University Consortium in 1993. Landi qualified for the associate professorship in occupational medicine and industrial hygiene in the Italian Universities in 1998.^[1]

Landi received tenure in the National Cancer Institute's division of cancer epidemiology and genetics (DCEG) in 2006.^[2] She is a senior investigator in the integrative tumor epidemiology branch.^[1] She is an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. Landi and her team conduct germline and somatic genomic analyses in population studies.^[2] In 2021, she was appointed senior advisor for genomic epidemiology in DCEG's trans-divisional research program.^[2] Landi's research focuses on understanding tumor etiology and evolution for potential translational applications. She leads large-scale multidisciplinary research projects primarily on genetic and environmental determinants of lung cancer and melanoma.^[2] Landi conducts analyses of genomic, transcriptomic, and epigenomic data, and integrates molecular data with histological and radiological imaging and clinical and epidemiological data.^[2] She also examines the role of dioxins in cancer risk among highly exposed populations, utilizing markers of exposure and early effect.^[2]

• Women in medicine
• List of Italian scientists
• List of Johns Hopkins University people